Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of laboratory services. The company also develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. In addition, it develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an MK2 inhibitor treatment for pancreatic and metastatic breast cancer. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Aclaris Therapeutics Inc..
Aclaris Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Aclaris Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Aclaris Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Aclaris Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Aclaris Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Aclaris Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
NA
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Aclaris Therapeutics Inc.- Key Facts
2.2 Aclaris Therapeutics Inc.- Geographic Locations
2.3 Aclaris Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Aclaris Therapeutics Inc.- Business Divisions
2.5 Aclaris Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Aclaris Therapeutics Inc. Strategic Analysis Review
3.1 Aclaris Therapeutics Inc.- Key Strategies
3.2 Aclaris Therapeutics Inc.- Company Outlook Statement
3.3 Aclaris Therapeutics Inc.- SWOT Analysis
3.3.1 Aclaris Therapeutics Inc.- Key Strengths
3.3.2 Aclaris Therapeutics Inc.- Key Weaknesses
3.3.3 Aclaris Therapeutics Inc.- Potential Opportunities
3.3.4 Aclaris Therapeutics Inc.- Potential Threats
3.4 Aclaris Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Aclaris Therapeutics Inc.- Business Overview
4.2 Aclaris Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Aclaris Therapeutics Inc.- Key Products
5.2 Aclaris Therapeutics Inc.- Key Service Areas
5.3 Aclaris Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Aclaris Therapeutics Inc.- Company History
6.2 Aclaris Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Aclaris Therapeutics Inc.- Income Statements
7.2 Aclaris Therapeutics Inc.- Balance Sheet
7.3 Aclaris Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Aclaris Therapeutics Inc.- Direct Competitors
8.2 Aclaris Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Aclaris Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Aclaris Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
NA
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
